Beckman Coulter
Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing.
Company Description
Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions, and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. Hospital laboratories are our core clinical diagnostic customers. Our life science customers include pharmaceutical and biotechnology companies, medical schools, and research institutions. Beckman Coulter has an installed base of more than 200,000 clinical and research systems operating in laboratories around the world. About 81% of Beckman Coulter's $3.3 billion annual revenue comes from recurring sources, such as consumable supplies (including reagent test kits), service and lease payments.
Chief Chromatographic Techniques Supported
- Capillary electrophoresis
- Protein analysis, CE-SDS, cIEF
- Analytical ultracentrifugation
- Carbohydrate analysis
- Ion analysis
- Chiral analysis
- UV-Visible spectroscopy
- Centrifugation
- Liquid handlers
- Particle characterization
- pH meters
- Flow cytometry
Markets Served
- Research and Development
- QA/QC
- Biopharmaceutical
- Forensics
- Academia
- Government
- Agricultural
- Industrial
- Clinical Diagnostics
Major Products/Services
Beckman Coulter provides a range of solutions to simplify, automate, and innovate complex biomedical testing. As the leader in capillary electrophoresis technology, we provide CE solutions that separate and characterize molecules, including counter-ions, nucleic acids, basic drugs, enantiomers, proteins, and carbohydrates, with high efficiency and reproducibility. Capillary electrophoresis solutions include the PA 800 plus Pharmaceutical Analysis System, PA 800 Protein Characterization System, and the P/ACE MDQ. Beckman Coulter's XL-A/XL-I Analytical Ultracentrifuge with native condition capability provides the ideal solution to satisfying the demands of the drug discovery process by characterizing a protein's behavior in free solution under physiological concentrations, temperatures, and buffer conditions.
Facilities
We conduct a variety of operations at approximately 15 owned and 121 leased facilities worldwide, including administration, R&D, hardware and consumables manufacturing, warehouse and distribution, marketing, sales, and service. Beckman Coulter's facilities often serve both our clinical diagnostics and life science segments.
Beckman Coulter
250 South Kraemer Blvd.
Brea, CA 92821
TELEPHONE
(800) 742-2345
WEB SITE
NUMBER OF EMPLOYEES
Worldwide: 11,000
YEAR FOUNDED
1935
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
